Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 3:13 pm Sale | 2020-12-31 | 13G | PRINCIPIA BIOPHARMA INC PRNB | Cormorant Asset Management LP | 0 0.000% | -1,990,922 (Position Closed) | Filing History |
| 2020-09-30 9:00 pm Sale | 2020-09-28 | 13D | PRINCIPIA BIOPHARMA INC PRNB | GSK plc | 0 0.000% | -3,042,193 (Position Closed) | Filing History |
| 2020-09-10 10:03 am Sale | 2020-09-09 | 13G | PRINCIPIA BIOPHARMA INC PRNB | FMR LLC | 352,167 1.059% | -4,565,765 (-92.84%) | Filing History |
| 2020-08-25 12:32 pm Unchanged | 2020-08-25 | 13D | PRINCIPIA BIOPHARMA INC PRNB | BIOTECHNOLOGY VALUE FUND L P | 5,231,900 15.700% | 0 (Unchanged) | Filing History |
| 2020-08-19 1:49 pm Purchase | 2020-08-17 | 13G | PRINCIPIA BIOPHARMA INC PRNB | BIOTECHNOLOGY VALUE FUND L P | 5,231,900 15.700% | 3,515,166 (+204.76%) | Filing History |